Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Peter Guengerich

Showing results (161-170 of 471) with videos related to

Pageof 48
Sort By:
Chemical Research in Toxicology|December 20, 2013
Human cytochrome P450 oxidation of 5-hydroxythalidomide and pomalidomide, an amino analogue of thalidomideGoutam Chowdhury, Norio Shibata, Hiroshi Yamazaki, et al.
Archives of Toxicology|June 1, 2022
Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactionsSlobodan P Rendić, Rachel D Crouch, F Peter Guengerich
Chemical Research in Toxicology|October 1, 2010
Mutagenicity of a glutathione conjugate of butadiene diepoxideSung-Hee Cho, Elisabeth M Loecken, F Peter Guengerich
Journal of Nucleic Acids|October 12, 2010
Mechanistic Studies with DNA Polymerases Reveal Complex Outcomes following Bypass of DNA DamageRobert L Eoff, Jeong-Yun Choi, F Peter Guengerich
Biochemical and Biophysical Research Communications|August 30, 2005
Function of human cytochrome P450s: characterization of the orphansF Peter Guengerich, Zhong-Liu Wu, Cheryl J Bartleson
The Journal of Biological Chemistry|October 11, 2005
Expansion of substrate specificity of cytochrome P450 2A6 by random and site-directed mutagenesisZhong-Liu Wu, Larissa M Podust, F Peter Guengerich
The Journal of Organic Chemistry|May 20, 2006
Chemical reactivity as a tool to study carcinogenicity: reaction between chloroethylene oxide and guanineUrban Bren, Mateja Zupan, F Peter Guengerich, et al.
The Journal of Biological Chemistry|January 15, 2021
Kinetics of cytochrome P450 3A4 inhibition by heterocyclic drugs defines a general sequential multistep binding processF Peter Guengerich, Kevin D McCarty, Jesse G Chapman
Drug Metabolism Reviews|January 6, 2006
"Phase I and Phase II" drug metabolism: terminology that we should phase out?P David Josephy, F Peter Guengerich, John O Miners
Journal of Biomolecular Structure & Dynamics|March 10, 2017
7,8-benzoflavone binding to human cytochrome P450 3A4 reveals complex fluorescence quenching, suggesting binding at multiple protein sitesGlenn A Marsch, Benjamin T Carlson, F Peter Guengerich
Pageof 48

Showing results (161-170 of 471) with videos related to

Sort By:
Pageof 48
Chemical Research in Toxicology|December 20, 2013
Human cytochrome P450 oxidation of 5-hydroxythalidomide and pomalidomide, an amino analogue of thalidomideGoutam Chowdhury, Norio Shibata, Hiroshi Yamazaki, et al.
Archives of Toxicology|June 1, 2022
Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactionsSlobodan P Rendić, Rachel D Crouch, F Peter Guengerich
Chemical Research in Toxicology|October 1, 2010
Mutagenicity of a glutathione conjugate of butadiene diepoxideSung-Hee Cho, Elisabeth M Loecken, F Peter Guengerich
Journal of Nucleic Acids|October 12, 2010
Mechanistic Studies with DNA Polymerases Reveal Complex Outcomes following Bypass of DNA DamageRobert L Eoff, Jeong-Yun Choi, F Peter Guengerich
Biochemical and Biophysical Research Communications|August 30, 2005
Function of human cytochrome P450s: characterization of the orphansF Peter Guengerich, Zhong-Liu Wu, Cheryl J Bartleson
The Journal of Biological Chemistry|October 11, 2005
Expansion of substrate specificity of cytochrome P450 2A6 by random and site-directed mutagenesisZhong-Liu Wu, Larissa M Podust, F Peter Guengerich
The Journal of Organic Chemistry|May 20, 2006
Chemical reactivity as a tool to study carcinogenicity: reaction between chloroethylene oxide and guanineUrban Bren, Mateja Zupan, F Peter Guengerich, et al.
The Journal of Biological Chemistry|January 15, 2021
Kinetics of cytochrome P450 3A4 inhibition by heterocyclic drugs defines a general sequential multistep binding processF Peter Guengerich, Kevin D McCarty, Jesse G Chapman
Drug Metabolism Reviews|January 6, 2006
"Phase I and Phase II" drug metabolism: terminology that we should phase out?P David Josephy, F Peter Guengerich, John O Miners
Journal of Biomolecular Structure & Dynamics|March 10, 2017
7,8-benzoflavone binding to human cytochrome P450 3A4 reveals complex fluorescence quenching, suggesting binding at multiple protein sitesGlenn A Marsch, Benjamin T Carlson, F Peter Guengerich
Pageof 48